![Antonin Rollet de Fougerolles](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Antonin Rollet de Fougerolles
Direktör/Styrelseledamot på
DEEPMATTER GROUP PLC
Profil
Antonin Rollet de Fougerolles is currently the Chairman at eTheRNA immunotherapies NV.
He is also a Director at Chimeron Bio Corp., Walking Fish Therapeutics, Inc., and a Non-Executive Director at ChemAI Ltd. Previously, he served as the Chief Executive Officer & Director at Evox Therapeutics Ltd. from 2018 to 2024.
He was the Chief Scientific Officer at Tolerx, Inc. in 2010-2011 and at Ablynx NV from 2013 to 2018.
Additionally, he held the position of VP-Research, Immunology, Metabolic & Viral Disease at Alnylam Pharmaceuticals, Inc. from 2009 to 2010.
Dr. de Fougerolles obtained a doctorate degree from Harvard University.
Aktiva positioner av Antonin Rollet de Fougerolles
| Företag | Position | Start |
|---|---|---|
| DEEPMATTER GROUP PLC | Direktör/Styrelseledamot | 2024-11-27 |
Walking Fish Therapeutics, Inc.
 Walking Fish Therapeutics, Inc. BiotechnologyHealth Technology Develops cell-based therapeutics to treat diseases | Direktör/Styrelseledamot | - |
Chimeron Bio Corp.
 Chimeron Bio Corp. Medical SpecialtiesHealth Technology Develops personalized immuno therapeutics for the treatment of cancer | Direktör/Styrelseledamot | - |
eTheRNA immunotherapies NV
 eTheRNA immunotherapies NV BiotechnologyHealth Technology Develops novel immunotherapies to overcome cancers and infectious diseases | Ordförande | 2024-07-10 |
Tidigare kända positioner av Antonin Rollet de Fougerolles
| Företag | Position | Slut |
|---|---|---|
Evox Therapeutics Ltd.
 Evox Therapeutics Ltd. BiotechnologyHealth Technology Develops transformational therapeutics | Verkställande Direktör | 2024-04-29 |
| ABLYNX | Teknisk/Vetenskaplig/F&U Direktör | 2018-02-01 |
Tolerx, Inc.
 Tolerx, Inc. BiotechnologyHealth Technology Manufactures biopharmaceutical products | Teknisk/Vetenskaplig/F&U Direktör | 2011-12-19 |
| ALNYLAM PHARMACEUTICALS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2010-01-01 |
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | Teknisk/Vetenskaplig/F&U Direktör | - |
Antonin Rollet de Fougerolless utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
66
Första gradens relationer
10
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 10 |
|---|---|
Tolerx, Inc.
Tolerx, Inc. BiotechnologyHealth Technology Manufactures biopharmaceutical products | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Develops and produces antibodies | Health Technology |
DeepMatter Group Plc
 DeepMatter Group Plc Packaged SoftwareTechnology Services Develops AI-powered predictive chemistry solutions | Technology Services |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | Health Technology |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology Develops novel immunotherapies to overcome cancers and infectious diseases | Health Technology |
Evox Therapeutics Ltd.
Evox Therapeutics Ltd. BiotechnologyHealth Technology Develops transformational therapeutics | Health Technology |
Chimeron Bio Corp.
Chimeron Bio Corp. Medical SpecialtiesHealth Technology Develops personalized immuno therapeutics for the treatment of cancer | Health Technology |
Walking Fish Therapeutics, Inc.
Walking Fish Therapeutics, Inc. BiotechnologyHealth Technology Develops cell-based therapeutics to treat diseases | Health Technology |
